Evidence mapPaperPMID 38620124Full record

ArticleEuropean journal of integrative medicine2023

Traditional Chinese medicine for the COVID-19 pandemic: An online cross-sectional survey among health care workers.

Xinyan Jin, Leqin Xu, Chunli Lu, Xue Xue, Xuehan Liu, Yuzhen Zhou, Xiaoyang Hu, Jianping Liu, Xiaohua Pei

Abstract read
In one paragraph

Article in European journal of integrative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinyan JinCentre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Leqin XuXiamen Hospital Affiliated of Beijing University of Chinese Medicine, Xiamen, 361001, China.
Chunli LuCentre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Xue XueThe First Clinical Medical School, Hubei University of Chinese Medicine, 430074, Wuhan, China.
Xuehan LiuCentre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Yuzhen ZhouXiamen Hospital Affiliated of Beijing University of Chinese Medicine, Xiamen, 361001, China.
Xiaoyang HuSchool of Primary Care, Population Sciences and Medical Education, Aldermoor Health Centre, University of Southampton, Southampton, SO17 1BJ, United Kingdom.
Jianping LiuCentre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
Xiaohua PeiXiamen Hospital Affiliated of Beijing University of Chinese Medicine, Xiamen, 361001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: : During the coronavirus disease (COVID-19) pandemic, health care workers (HCWs) have faced a heightened risk of infection. Preventative measures are critical to mitigate the spread of COVID-19 and protect HCWs. Traditional Chinese medicine (TCM) has been recommended to prevent and treat COVID-19 in China. We conducted this survey to investigate the use of infection control behaviors, preventative and therapeutic interventions, and outcomes among HCWs during the surge of Omicron variant infections to explore the association of preventative measures with outcomes and to investigate the factors influencing the adoption of TCM as a preventative measure. Methods: : The questionnaire consisted of 23 sections with 154 questions intended for HCWs. The targeted respondents comprised all HCWs from Xiamen Hospital Affiliated of Beijing University of Chinese Medicine. The recruitment process was open between March 17 and June 1, 2022. Chi-square test was used to estimate the relationship between prevention and outcomes. Multivariable logistic regression was used to investigate factors influencing the use of TCM as a preventative measure. Results: : Among the 1122 participants who completed the questionnaire, 79.71% took preventative measures, including TCM (56.21%), physical activities (52.37%) and food supplements (26.99%). Xiamen preventative formula (a government-approved fixed prescription) (45.22%) and Lianhua Qingwen preparations (18.95%) were the most commonly used Chinese medicines. Thirty-six participants reported flu-like symptoms and three were diagnosed with COVID-19. Flu-like symptoms were not associated with prevention, vaccination, or TCM. Frontline working experience (OR = 0.61, 95% CI: 0.46-0.80), good knowledge of post-COVID-19 syndrome (OR = 0.57, 95% CI: 0.39-0.84), Western medicine qualifications (OR = 2.41, 95% CI: 1.51-3.86), nurses (OR = 1.70, 95% CI: 1.21-2.40), and medical technicians (OR = 2.27, 95% CI: 1.25-4.10) were associated with the willingness of using TCM as a preventative measure. Conclusion: : Complementary medicine, especially TCM, could be used for COVID-19 prevention. Knowledge of COVID-19 may prompt people to use TCM to prevent COVID-19. Multicenter studies and prospective cohort follow-up studies are needed to provide further insights into the use of TCM for COVID-19 management.

Indexed as

Chinese herbscomplementary therapyhealthcare personnelnon-pharmacological interventionOmicron variantretrospective treatment outcome

Identifiers

PMID38620124
PMCPMC10293119

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.